Navigating the mRNA-LNP patent labyrinth: advice for developers

“It is crucial that companies confer with their patent counsel early, and deeply consider their formulations in the context of the patent landscape...”

Institutions

Publication Details

Journal
Vaccine Insights
Published
2024-11-07
DOI
https://doi.org/10.18609/vac.2024.036
Primary Topic
Intellectual Property and Patents
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Navigating the mRNA-LNP patent labyrinth: advice for developers

Vaccine Insights
Intellectual Property and Patents
article

Navigating the mRNA-LNP patent labyrinth: advice for developers

article en

Abstract

“It is crucial that companies confer with their patent counsel early, and deeply consider their formulations in the context of the patent landscape...”

Vaccine InsightsVol. 3(6)
Roth and Rau (Germany) (DE)
Openalex Percentile: Top 31%
Intellectual Property and Patents
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Navigating the mRNA-LNP patent labyrinth: advice for developers · Vaccine Insights (2024) | TGRS Research Map | TGRS